# Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

> **NCT00004986** · PHASE3 · TERMINATED · sponsor: **Romark Laboratories L.C.** · enrollment: 30 (—)

## Conditions studied

- Cryptosporidiosis
- HIV Infections

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT00004986
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004986, "Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*